![]() |
市場調査レポート
商品コード
1630646
動物用免疫診断薬市場規模、シェア、成長分析、製品別、技術別、動物の種類別、疾患タイプ別、エンドユーザー別、地域別 - 産業予測、2025-2032年Veterinary Immunodiagnostics Market Size, Share, Growth Analysis, By Product (CONSUMABLES, INSTRUMENTS), By Technology (CLINICAL BIOCHEMISTRY, Molecular Diagnostics), By Animal Type, By Disease Type, By End User, By Region - Industry Forecast 2025-2032 |
||||||
|
動物用免疫診断薬市場規模、シェア、成長分析、製品別、技術別、動物の種類別、疾患タイプ別、エンドユーザー別、地域別 - 産業予測、2025-2032年 |
出版日: 2025年01月09日
発行: SkyQuest
ページ情報: 英文 165 Pages
納期: 3~5営業日
|
動物用免疫診断薬の世界市場規模は、2023年に27億米ドルと評価され、2024年の29億2,000万米ドルから2032年には54億4,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは8.1%で成長する見通しです。
動物用免疫診断薬市場は、動物疾病の蔓延、疾病特異的免疫診断検査の登場、診断技術の進歩など、いくつかの要因によって力強い成長を遂げています。ペットの飼育数の急増と動物由来食品への需要の高まりが、この拡大をさらに後押ししています。新興経済諸国は、発展途上地域においては獣医学的診断インフラが不十分ではありますが、大きな成長機会をもたらしています。現在進行中のCOVID-19パンデミックは、ヒトと動物の両方に対する検査率を高めており、検査施設は動物検査ソリューションの革新を余儀なくされています。AVMAやCDCのような組織は、動物に対するルーチンのCOVID-19検査を推奨していませんが、進展する状況に基づいて保健当局が決定を下すこともあり、獣医師と保健当局の協力の重要性が浮き彫りになっています。
Global Veterinary Immunodiagnostics Market size was valued at USD 2.7 billion in 2023 and is poised to grow from USD 2.92 billion in 2024 to USD 5.44 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).
The veterinary immunodiagnostics market is experiencing robust growth driven by several factors, including the increased prevalence of animal diseases, the advent of disease-specific immunodiagnostic tests, and advancements in diagnostic technology. A surge in pet ownership and rising demand for animal-derived food products further fuel this expansion. Emerging economies present significant growth opportunities, despite challenges posed by inadequate veterinary diagnostic infrastructure in developing regions. The ongoing COVID-19 pandemic has heightened testing rates for both humans and animals, compelling laboratories to innovate animal testing solutions. Although organizations like the AVMA and CDC do not endorse routine COVID-19 testing for animals, the decision may be prompted by health officials based on evolving circumstances, underscoring the importance of collaboration between veterinarians and health authorities.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Immunodiagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Veterinary Immunodiagnostics Market Segmental Analysis
Global Veterinary Immunodiagnostics Market is segmented by Product, Technology, Animal Type, Disease Type, End User and region. Based on Product, the market is segmented into Consumables and Instruments. Based on Technology, the market is segmented into Clinical Biochemistry, Molecular Diagnostics, Hematology, Urinalysis, Immunodiagnostics and Other Veterinary Diagnostic Technologies. Based on Animal Type, the market is segmented into Companion Animals and Livestock. Based on Disease Type, the market is segmented into Infectious Disease, Endocrinology, Oncology, Cardiology and Others. Based on End User, the market is segmented into Veterinary Reference Laboratories, Veterinary Hospitals & Clinics, Point-of-care/ In-house Testing and Veterinary Research Institutes & Universities. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Veterinary Immunodiagnostics Market
The Global Veterinary Immunodiagnostics market is significantly driven by the potential transmission of serious zoonotic illnesses from animals to humans. At least 30 major diseases, including rabies, leptospirosis, and zoonotic tuberculosis, can spread through livestock and companion animals such as dogs and cats. The increasing prevalence of transboundary diseases, exemplified by foot-and-mouth disease affecting a large portion of livestock globally, further underscores the need for effective immunodiagnostic tools. Additionally, the emergence of zoonotic sources such as those linked to the COVID-19 pandemic highlights the critical role veterinary diagnostics play in safeguarding public health and preventing future outbreaks, ultimately fostering market growth.
Restraints in the Global Veterinary Immunodiagnostics Market
The Global Veterinary Immunodiagnostics market faces significant restraints due to the rising costs associated with pet care over the last decade. Research indicates that veterinary care represents the second-largest spending category within the pet care industry, with the U.S. alone contributing over $18.11 billion, marking a 6.1% increase from the previous year. High-end veterinary procedures can range from $5,000 to $20,000, while typical diagnostic costs for assessing antimicrobial resistance or infections using advanced techniques like PCR are notably steep. The reliance on expensive materials and cutting-edge technologies for treatments makes pet owners and veterinarians reluctant to invest heavily in diagnostic services.
Market Trends of the Global Veterinary Immunodiagnostics Market
The Global Veterinary Immunodiagnostics market is poised for significant growth, driven by the rising prevalence of zoonotic and vector-borne diseases linked to climate change, habitat modification, and evolving social dynamics. As these diseases become more common, there is an increasing need for rapid and precise diagnostic tools, particularly in companion animal medicine in developed countries. This trend is further fueled by a growing preference for advanced diagnostic technologies, such as RT-PCR, over traditional methods. Consequently, veterinary immunodiagnostics will play a critical role in disease management and prevention, positioning itself as a vital segment within the broader veterinary diagnostics market.